21696 results for «»

Filter By

21696 results

Case-based challenges and dilemmas in multivessel PCI

21 May 2026 – From EuroPCR 2026

This session addresses real-world challenges in multivessel PCI for stable and acute coronary syndromes, emphasizing decision-making, procedure planning, and complication management. It highlights the application of imaging, physiology, and contemporary tools such as DCB to optimize outcomes through illustrative cases from Bangladesh, Brunei Darussalam, and the...

SCAD, PCI specific strategies

21 May 2026 – From EuroPCR 2026

This session focuses on specific percutaneous coronary intervention strategies for spontaneous coronary artery dissection (SCAD) and related coronary anomalies. It covers clinical and therapeutic aspects of adult coronary aneurysms, woven coronary anomalies, innovative stent optimization techniques, microvascular dysfunction in takotsubo syndrome, and real-world management of SCAD...

Complication management after tricuspid valve interventions

21 May 2026 – From EuroPCR 2026

This session reviews complication management following tricuspid valve interventions, highlighting practical approaches to unexpected procedural events. Topics include management of TricValve pop-up complications, Evoque device challenges, acute leaflet thrombosis emergencies, and bailout strategies for single leaflet detachment in tricuspid transcatheter edge-to-edge repair (TEER).

Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026

27 May 2026

Shockwave C2 Aero: Early experience in complex calcified coronary lesions

27 May 2026

Dr. Yousif Ahmad and Dr. Brett Wanamaker discuss how improved deliverability may influence calcium modification strategies in complex PCI.

In this case-based discussion, Dr. Yousif Ahmad and Dr. Brett Wanamaker share their early experience with Shockwave C2 Aero in complex calcified coronary anatomy. Through challenging real-world cases,...

Shockwave C2 Aero: Early experience in complex calcified coronary lesions

EuroPCR 2026: Elixir Medical's DynamX® bioadaptor demonstrates significantly lower event rates than drug-eluting stent in long-term follow-up, including reduction in cardiovascular death

19 May 2026

The next frontier of DCB is to simplify complexity

29 May 2026

Register for free to this webinar on Monday 29 June at 5:00pm with F. Ribichini and A. Monayer, B. Scheller, P. Suwannasom and learn how to understand the role and potential advantages of DCBs in complex patients and lesions, and much more! ...

The next frontier of DCB is to simplify complexity

Antonella Potenza

Milan, Italy

Giovanni Panzacchi

Milan, Italy

Diego Salerno Uriarte

Milan, Italy

Marco Guazzi

Milan, Italy

Intravascular lithotripsy in comparison to rotational atherectomy for calcified lesions: the ICARE OFDI randomised trial

01 Jun 2026

In patients with moderate-to-severe calcified coronary lesions, ICARE OFDI evaluates IVL versus rotational atherectomy as lesion preparation strategies, with OFDI-based assessment of stent results.

Emanuele Gallinoro

Reviewer

Emanuele Gallinoro
ICARE OFDI: IVL vs rotational atherectomy for calcified lesions

Side branch additional treatment for coronary bifurcation lesion revascularisation: insights from the KISS randomised trial

01 Jun 2026

In patients with non-left main coronary bifurcation lesions treated with provisional stenting and POT, the KISS randomised trial compares a strategy of no side branch intervention versus systematic side branch treatment.

Reviewer

Aaysha Cader
KISS trial: side branch strategy in coronary bifurcation PCI

Refactory angina and coronary sinus reducer, from established applications to future outlooks

21 May 2026 – From EuroPCR 2026

In this discussion, Tim van de Hoef and Tommaso Gori explore the evolving definition of refractory angina, extending beyond obstructive disease to include non-obstructive and microvascular conditions. They highlight the challenges of recognition, driven by variability in symptoms, diagnostic approaches, and clinical practices, and stress that...

Refactory angina and coronary sinus reducer, from established applications to future outlooks

Sirolimus-eluting balloon vs. repeat drug-eluting stent or balloon angioplasty for coronary in-stent restenosis

03 Jun 2026

In-stent restenosis remains the Achilles heel of PCI. Drug-eluting balloons offer a potential strategy for the treatment of in-stent restenosis. To date, implantation of a further drug-eluting stent provide better long-term outcomes compared to paclitaxel drug-eluting balloons.

In this trial, the authors compare the safety and efficacy...

Judit Andréka

Reviewer

Judit Andréka
Nicola Ryan

Reviewer

Nicola Ryan
Sirolimus-eluting balloon vs. repeat drug-eluting stent or balloon angioplasty for coronary in-stent restenosis

Practical solutions to grow your TAVI programme - peer-to-peer case sharing

23 Nov 2021 – From PCR London Valves 2021

Thanks to this PCR London Valves 2021 session, explore real-world examples of how to use digital communication successfully with your referral network, discover practical ways to implement a TAVI nurse programme in your hospital and learn how to obtain resources and support from your hospital management...

Practical solutions to grow your TAVI programme - peer-to-peer case sharing

Procedural aspects of TAVI patient long-term management

22 Nov 2021 – From PCR London Valves 2021

At the PCR London Valves 2021 Congress, a session was proposed to discuss long-term management of TAVI patients: gain knowledge in procedural PCI access after TAVI through case examples, and learn more about the essential steps of the cusp overlap implantation technique by watching it now!

Procedural aspects of TAVI patient long-term management

Outcomes of TAVI devices

21 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session on TAVI compiles the results of various clinical studies conducted on different valve models on the market today and in the future: J-valve, Acurate Neo-2, Perimount P 2900, and many others.

Outcomes of TAVI devices

Edwards' transcatheter trilogy: an exclusive portfolio of three options to treat tricuspid regurgitation

22 Nov 2021 – From PCR London Valves 2021

In this session broadcast at PCR London Valves 2021, discuss and explore transcatheter therapies for the treatment of tricuspid regurgitation and their clinical impact, analyze the recorded live case of an 81-year-old female patient from Leipzig, and discover the potential of transcatheter replacement technologies in the...

Edwards' transcatheter trilogy: an exclusive portfolio of three options to treat tricuspid regurgitation

New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management

21 Nov 2021 – From PCR London Valves 2021

Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...

New 2021 ESC heart failure
Didn’t find what you were looking for?